|
ZNF25 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64760000087583E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.11950498555325E-11 |
| Normal-vs-Stage2 |
7.396200E-03 |
| Normal-vs-Stage3 |
3.231600E-02 |
| Normal-vs-Stage4 |
3.566000E-01 |
| Stage1-vs-Stage2 |
8.302200E-01 |
| Stage1-vs-Stage3 |
4.577200E-04 |
| Stage1-vs-Stage4 |
5.66589999999589E-05 |
| Stage2-vs-Stage3 |
1.094180E-01 |
| Stage2-vs-Stage4 |
3.944400E-02 |
| Stage3-vs-Stage4 |
3.836000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.03840003052147E-09 |
| Normal-vs-AfricanAmerican |
3.441400E-01 |
| Normal-vs-Asian |
2.383600E-01 |
| Caucasian-vs-AfricanAmerican |
4.153600E-02 |
| Caucasian-vs-Asian |
7.434400E-01 |
| AfricanAmerican-vs-Asian |
2.537200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.72439999945873E-07 |
| Normal-vs-Female |
2.36619999999244E-05 |
| Male-vs-Female |
8.504600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.078500E-02 |
| Normal-vs-Age(41-60Yrs) |
1.97119999989503E-07 |
| Normal-vs-Age(61-80Yrs) |
2.15149999999165E-05 |
| Normal-vs-Age(81-100Yrs) |
2.230200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.440600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.182400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.390800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.033200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.165600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.560800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.083700E-03 |
| Normal-vs-Grade 2 |
7.83850762076099E-12 |
| Normal-vs-Grade 3 |
2.678100E-03 |
| Normal-vs-Grade 4 |
9.424400E-01 |
| Grade 1-vs-Grade 2 |
1.838190E-01 |
| Grade 1-vs-Grade 3 |
8.383600E-04 |
| Grade 1-vs-Grade 4 |
8.30870000000372E-05 |
| Grade 2-vs-Grade 3 |
3.60050000000056E-05 |
| Grade 2-vs-Grade 4 |
3.06360000035255E-07 |
| Grade 3-vs-Grade 4 |
4.331800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.21014309684142E-14 |
| Normal-vs-ccB subtype |
3.596400E-02 |
| ccA subtype-vs-ccB subtype |
2.94490000052328E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.98484999999193E-05 |
| Normal-vs-N1 |
5.484600E-01 |
| N0-vs-N1 |
3.966800E-01 |
|
|
